Cargando…

Mutational signature and clonal relatedness of recurrent urothelial carcinomas with aristolochic acid

Urothelial carcinomas (UCs) are malignant tumors that arise from the lower and upper urinary tract and are characterized by multiple recurrences. Aristolochic acid (AA) is a potent nephrotoxin and human carcinogen associated with UC. East Asian populations with a high UC prevalence have an unusual g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jie, Ai, Qing, Cheng, Qiang, Shen, Dan, Dong, Zhouhuan, Li, Jie, Shen, Donglai, Wang, Wei, Zhang, Xu, Li, Hongzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516318/ https://www.ncbi.nlm.nih.gov/pubmed/36185218 http://dx.doi.org/10.3389/fonc.2022.990023

Ejemplares similares

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs
por: Yang, Huang-Yu, et al.
Publicado: (2019)

Mutation signatures implicate aristolochic acid in bladder cancer development
por: Poon, Song Ling, et al.
Publicado: (2015)

Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
por: Lim, Abner Herbert, et al.
Publicado: (2022)

Aristolochic Acid Affects Upper Tract Urothelial Cancer Behavior through the MAPK Pathway
por: Chen, I-Hsuan, et al.
Publicado: (2019)

Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma
por: Boot, Arnoud, et al.
Publicado: (2020)

APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer
por: Natesan, Divya, et al.
Publicado: (2022)

Comparison of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Patients With Complete Upper Pole Renal Tumors
por: Gu, Liangyou, et al.
Publicado: (2022)

Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo
por: TAO, LE, et al.
Publicado: (2015)

Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma
por: Jhuang, Jing-Rong, et al.
Publicado: (2023)

Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome
por: Guan, Bao, et al.
Publicado: (2022)

A test for clonal relatedness in a set of lymphocytes
Publicado: (1990)

Clonal relatedness in tumour pairs of breast cancer patients
por: Biermann, Jana, et al.
Publicado: (2018)

PB1860: CLONALITY RELATEDNESS AND MOLECULAR CHARACTERISTICS OF RICHTER SYNDROME
por: Sha, Y., et al.
Publicado: (2022)

Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
por: Li, Chun, et al.
Publicado: (2022)

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)

Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder
por: Okubo, Kazuki, et al.
Publicado: (2020)

Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
por: Colin, Pierre, et al.
Publicado: (2016)

Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure
por: Karanović, Sandra, et al.
Publicado: (2021)

Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
por: Hayashi, Yujiro, et al.
Publicado: (2021)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma
por: Xu, Chaojie, et al.
Publicado: (2022)

Recurrent papillary renal cell carcinoma with concomitant ipsilateral upper urinary tract urothelial carcinoma and metachronous urothelial carcinoma of the bladder
por: Banapour, Pooya, et al.
Publicado: (2018)

High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan
por: Lai, Hong-Yue, et al.
Publicado: (2022)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions
por: Andrade, Victor P, et al.
Publicado: (2012)

A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma
por: Li, Xiaoqi, et al.
Publicado: (2021)

Preparation of Anti-Aristolochic Acid I Monoclonal Antibody and Development of Chemiluminescent Immunoassay and Carbon Dot-Based Fluoroimmunoassay for Sensitive Detection of Aristolochic Acid I
por: Ou, Ai-Fen, et al.
Publicado: (2021)

Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia
por: Hurtado, A M, et al.
Publicado: (2015)

Urothelial Carcinoma Recurrence at an Ileal Orthotopic Neobladder and Unilateral Lower Ureter After Surgery
por: Kawamoto, Bunya, et al.
Publicado: (2016)

DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer
por: Stiborová, Marie, et al.
Publicado: (2017)

Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy
por: Shan, Hongli, et al.
Publicado: (2020)

Comparison Between Urothelial and Non-Urothelial Urethral Cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents
por: Li, Xi-Lin, et al.
Publicado: (2020)

Overview of aristolochic acid nephropathy: an update
por: Zhou, Qingqing, et al.
Publicado: (2023)

The Ginsenoside Rg(1) Rescues Mitochondrial Disorders in Aristolochic Acid-Induced Nephropathic Mice
por: Chou, Chu-Kuang, et al.
Publicado: (2021)

Catalog of Lung Cancer Gene Mutations Among Chinese Patients
por: Xue, Xinying, et al.
Publicado: (2020)

Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers
por: Stiborová, Marie, et al.
Publicado: (2008)

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
por: Lee, Boram, et al.
Publicado: (2021)

Port Site Recurrence Following a Robotic Laparoscopic Radical Nephroureterectomy for Sarcomatoid Variant of Urothelial Carcinoma
por: Katz, Jonathan Elliott, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cr4t6lee70o35bp8lnko65c3m9